Current and historical daily PE Ratio for Blau Farmaceutica (
BSP:BLAU3
) from 2021 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Blau Farmaceutica stock (BSP:BLAU3) PE ratio as of May 15 2024 is 7.47.
More Details
Blau Farmaceutica SA (BSP:BLAU3) PE Ratio (TTM) Chart
Blau Farmaceutica SA (BSP:BLAU3) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 800
- 1
- 2
- 3
- 4
- 5
- 6
- 9
| Blau Farmaceutica PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-15 | 7.5 | 2024-03-12 | 8.5 |
| 2024-05-14 | 7.5 | 2024-03-11 | 8.4 |
| 2024-05-13 | 7.6 | 2024-03-08 | 8.6 |
| 2024-05-10 | 7.7 | 2024-03-07 | 8.6 |
| 2024-05-09 | 7.9 | 2024-03-06 | 8.7 |
| 2024-05-08 | 7.6 | 2024-03-05 | 8.8 |
| 2024-05-07 | 7.5 | 2024-03-04 | 8.7 |
| 2024-05-06 | 7.3 | 2024-03-01 | 9.0 |
| 2024-05-03 | 7.5 | 2024-02-29 | 8.8 |
| 2024-05-02 | 7.3 | 2024-02-28 | 8.9 |
| 2024-04-30 | 7.1 | 2024-02-27 | 8.9 |
| 2024-04-29 | 7.5 | 2024-02-26 | 8.7 |
| 2024-04-26 | 7.7 | 2024-02-23 | 8.7 |
| 2024-04-25 | 7.2 | 2024-02-22 | 9.1 |
| 2024-04-24 | 7.4 | 2024-02-21 | 9.0 |
| 2024-04-23 | 7.6 | 2024-02-20 | 8.7 |
| 2024-04-22 | 7.3 | 2024-02-19 | 8.7 |
| 2024-04-19 | 7.3 | 2024-02-16 | 8.7 |
| 2024-04-18 | 7.3 | 2024-02-15 | 8.4 |
| 2024-04-17 | 7.4 | 2024-02-14 | 8.4 |
| 2024-04-16 | 7.6 | 2024-02-13 | 8.5 |
| 2024-04-15 | 7.8 | 2024-02-12 | 8.5 |
| 2024-04-12 | 8.2 | 2024-02-09 | 8.5 |
| 2024-04-11 | 8.5 | 2024-02-08 | 8.7 |
| 2024-04-10 | 8.6 | 2024-02-07 | 8.9 |
| 2024-04-09 | 8.5 | 2024-02-06 | 8.4 |
| 2024-04-08 | 8.5 | 2024-02-05 | 8.3 |
| 2024-04-05 | 8.5 | 2024-02-02 | 8.4 |
| 2024-04-04 | 8.6 | 2024-02-01 | 8.7 |
| 2024-04-03 | 8.7 | 2024-01-31 | 8.7 |
| 2024-04-02 | 8.7 | 2024-01-30 | 8.7 |
| 2024-04-01 | 8.4 | 2024-01-29 | 8.9 |
| 2024-03-29 | 8.8 | 2024-01-26 | 9.0 |
| 2024-03-28 | 8.8 | 2024-01-25 | 9.1 |
| 2024-03-27 | 8.7 | 2024-01-24 | 9.3 |
| 2024-03-26 | 8.6 | 2024-01-23 | 9.1 |
| 2024-03-25 | 8.5 | 2024-01-22 | 9.0 |
| 2024-03-22 | 8.7 | 2024-01-19 | 9.4 |
| 2024-03-21 | 8.5 | 2024-01-18 | 9.7 |
| 2024-03-20 | 8.8 | 2024-01-17 | 10.3 |
| 2024-03-19 | 8.5 | 2024-01-16 | 10.3 |
| 2024-03-18 | 8.4 | 2024-01-15 | 10.7 |
| 2024-03-15 | 8.4 | 2024-01-12 | 10.9 |
| 2024-03-14 | 8.4 | 2024-01-11 | 11.0 |
| 2024-03-13 | 8.6 | 2024-01-10 | 10.9 |
Blau Farmaceutica SA (BSP:BLAU3) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Blau Farmaceutica SA
ISIN : BRBLAUACNOR8
Compare
Compare
Traded in other countries / regions
BLAU3.Brazil IPO Date
2021-04-19Description
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers